A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Boehringer Ingelheim1,164 enrolled

Overview

Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.

Study Type

OBSERVATIONAL

Enrollment

1,164

Conditions

Diabetes Mellitus, Type 2

Interventions

TRADIANCE® Combination Tablets APDRUG

Fixed dose combination

TRADIANCE® Combination Tablets BPDRUG

Fixed dose combination

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Japanese patients with Type 2 Diabetes mellitus (T2DM) who are prescribed with TRADIANCE® Combination Tablets AP or BP * Patients who have never been treated with TRADIANCE® Combination Tablets AP or BP before enrolment Exclusion Criteria: None

Locations (1)

Nippon Boehringer Ingelheim Co., Ltd

Tokyo, Japan

Outcomes

Primary Outcomes

Number of Participants With Adverse Drug Reactions (ADRs)

The number of participants with adverse drug reactions is reported.

Time frame: From first dose of study medication until last dose + 7 days, up to 102.1 weeks.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.